Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Replimune Group Inc (DE:7R8)
MUNICH:7R8
Replimune Group (7R8) Stock Price & Analysis
0 Followers
7R8 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€6.25 - €22.80
Previous Close€6.4
Volume0.00
Average Volume (3M)311.00
Market Cap
€371.21M
Enterprise Value€3.35M
Total Cash (Recent Filing)$466.35M
Total Debt (Recent Filing)$75.81M
Price to Earnings (P/E)N/A
Beta0.15
Next Earnings
May 16, 2024EPS Estimate
-€0.72Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume311
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.02
Forecast
1Y Price Target
€12.19Price Target Upside90.43% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Replimune Group News
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
0.24% Other Institutional Investors
99.76% Public Companies and
Individual Investors
7R8 FAQ
What was Replimune Group Inc’s price range in the past 12 months?
Replimune Group Inc lowest stock price was €6.25 and its highest was €22.80 in the past 12 months.
What is Replimune Group Inc’s market cap?
Currently, no data Available
When is Replimune Group Inc’s upcoming earnings report date?
Replimune Group Inc’s upcoming earnings report date is May 16, 2024 which is in 20 days.
How were Replimune Group Inc’s earnings last quarter?
Replimune Group Inc released its earnings results on Feb 08, 2024. The company reported -€0.725 earnings per share for the quarter, beating the consensus estimate of -€0.84 by €0.115.
Is Replimune Group Inc overvalued?
According to Wall Street analysts Replimune Group Inc’s price is currently Undervalued.
Does Replimune Group Inc pay dividends?
Replimune Group Inc does not currently pay dividends.
What is Replimune Group Inc’s EPS estimate?
Replimune Group Inc’s EPS estimate is -€0.72.
How many shares outstanding does Replimune Group Inc have?
Currently, no data Available
What happened to Replimune Group Inc’s price movement after its last earnings report?
Replimune Group Inc reported an EPS of -€0.725 in its last earnings report, beating expectations of -€0.84. Following the earnings report the stock price went up 9.353%.
Which hedge fund is a major shareholder of Replimune Group Inc?
Among the largest hedge funds holding Replimune Group Inc’s share is Baker Bros Advisors LP. It holds Replimune Group Inc’s shares valued at 80M.
---
Replimune Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€12.19 (90.43% Upside)
€12.19 (90.43% Upside)
Blogger Sentiment
Bullish
DE:7R8 Sentiment 100%
Sector Average 70%
Sector Average 70%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-61.74%
12-Months-Change
Fundamentals
Return on Equity
-41.29%
Trailing 12-Months
Asset Growth
-21.46%
Trailing 12-Months
Company Description
Replimune Group Inc
Replimune Group, Inc. is a clinical-stage biotechnology company, which engages in the development of oncolytic immunotherapy product candidates through immulytic platform. Oncolytic immunotherapy is a cancer treatment that exploits the ability of certain viruses to selectively replicate in an direct kill turmors, as well as induce a potent, patient-specific, anti-tumor immune response. The company was founded by Philip Astley-Sparke, Colin Love and Robert Coffin in March 2015 and is headquartered in Woburn, MA.
---
7R8 Stock 12 Months Forecast
Average Price Target
€12.19
▲(90.43% Upside)
Technical Analysis
Replimune Group
―
Adverum Biotechnologies
―
Arcturus Therapeutics
―
Meiragtx Holdings
―
Gritstone Oncology
―
Best Analysts Covering 7R8
1 Year
1 Year Success Rate
5/11 ratings generated profit
1 Year Average Return
+3.41%
reiterated a buy rating 3 months ago
Copying Robert Driscoll's trades and holding each position for 1 Year would result in 45.45% of your transactions generating a profit, with an average return of +3.41% per trade.
---